CLPT250117C2500
- 6.60
- 0.000.00%
ClearPoint Neuro Newsroom
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Announces Target Price $17
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating
Stifel Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Raises Target Price to $17
B.Riley Financial Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Raises Target Price to $15
B. Riley Adjusts Price Target on ClearPoint Neuro to $15 From $14, Maintains Buy Rating
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Raises Target Price to $15
ClearPoint Neuro Price Target Raised to $15.00/Share From $11.00 by Lake Street
ClearPoint Neuro Analyst Ratings
Lake Street Maintains Buy on ClearPoint Neuro, Raises Price Target to $15
Stifel Nicolaus Keeps Their Buy Rating on ClearPoint Neuro (CLPT)
B. Riley Adjusts Price Target on ClearPoint Neuro to $10.50 From $10, Maintains Buy Rating
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating
Lake Street Maintains ClearPoint Neuro(CLPT.US) With Buy Rating
Lake Street Remains a Buy on ClearPoint Neuro (CLPT)
B.Riley Financial Maintains ClearPoint Neuro(CLPT.US) With Buy Rating, Maintains Target Price $10